Caverject and Injection site pain - a phase IV clinical study of FDA data

Summary:

Injection site pain is reported as a side effect among people who take Caverject (alprostadil), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lipitor, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Injection site pain when taking Caverject. It is created by eHealthMe based on reports of 2,123 people who have side effects when taking Caverject from the FDA, and is updated regularly.

What is Caverject?

Caverject has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,144 Caverject users. Check the latest studies of Caverject.

What is Injection site pain?

Injection site pain is found to be associated with 1,872 drugs and 1,944 conditions by eHealthMe. Check the latest studies of Injection site pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

2,123 people reported to have side effects when taking Caverject.
Among them, 91 people (4.29%) have Injection site pain.

Could Caverject cause Injection site pain?

Among these 91 people:

How long have people been on Caverject when they have Injection site pain? *

What is the gender of people who have Injection site pain when taking Caverject? *

female: 0.0 %
male: 100 %

What is the age of people who have Injection site pain when taking Caverject? *

What are other drugs people take besides Caverject? *

What are other side effects people have besides Injection site pain? *

Drug Ineffective: 40 people, 43.96%
Penile Pain: 7 people, 7.69%
Injection Site Haemorrhage (bleeding from injection site): 6 people, 6.59%
Injection Site Erythema (redness at injection site): 5 people, 5.49%
Erection Increased: 5 people, 5.49%
Penis Disorder: 4 people, 4.40%
Painful Erection: 4 people, 4.40%
Drug Effect Decreased: 4 people, 4.40%
Injection Site Bruising: 3 people, 3.30%
Product Solubility Abnormal: 3 people, 3.30%

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 5.49%
Depression: 4 people, 4.40%
Nerve Injury: 4 people, 4.40%
Cardiac Disorder: 3 people, 3.30%
Bone Disorder: 3 people, 3.30%
Memory Loss: 3 people, 3.30%
Arthropathy: 3 people, 3.30%
Blood Glucose Abnormal: 2 people, 2.20%
Diabetes: 2 people, 2.20%
Blood Testosterone Decreased: 2 people, 2.20%

* Approximation only. Some reports may have incomplete information.

Do you take Caverject and have Injection site pain?

- Check whether Injection site pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Caverject:

Caverject (2,144 reports)

Browse all side effects of Caverject:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site pain:

Injection site pain (1,872 drugs)

Browse all the conditions that are associated with Injection site pain:

Injection site pain (1,944 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil (the active ingredients of Caverject) and Caverject (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.